Using a multiplex sensor array, Kim et al. showed that a lower Aβ42/Aβ40 ratio and a higher plasma t-tau/Aβ42 and p-tau 181/Aβ42 ratios successfully discriminated AD patients from healthy controls [78]. This evidence concerns the gene MAPT and Alzheimer disease.